Mon. 25 Mar 2024, 7:32am ET
Benzinga
Earnings, News
Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(1.14) per share which beat the analyst consensus estimate of $(1.28) by 10.94 percent. This is a 12.98 percent increase over losses of $(1.31) per share from the same period last year.